Evaluation of periapical injection of ketorolac for management of endodontic pain

Susan G. Penniston, Kenneth M. Hargreaves

Producción científica: Articlerevisión exhaustiva

41 Citas (Scopus)


Effective pain management of the endodontic emergency patient is often a problem. Ketorolac tromethamine is the first nonsteroidal anti-inflammatory drug available for intramuscular injection in the United States. Although its analgesic efficacy is comparable with opiates after intramuscular injection, to date no study has evaluated its efficacy after intraoral periapical injection. Fifty-two endodontic emergency patients were injected (injection routes = intraoral infiltration/intramuscular deltoid) on a double-blind basis with either: (i) placebo/placebo, (ii) 30 mg ketorolac/placebo, (iii) placebo/30 mg ketorolac, or (iv) 2% mepivicaine with 1:20 K levonordefrin/placebo. Infiltration injection of ketorolac at on oral site produced significant analgesic effects, particularly in treating pain of mandibular origin. These results suggest that intraoral injection of ketorolac may prove to be a useful adjunct in the management of endodontic pain patients. Further studies are required to replicate these findings and to develop optimal treatment combinations.

Idioma originalEnglish (US)
Páginas (desde-hasta)55-59
Número de páginas5
PublicaciónJournal of endodontics
EstadoPublished - 1996
Publicado de forma externa

ASJC Scopus subject areas

  • General Dentistry


Profundice en los temas de investigación de 'Evaluation of periapical injection of ketorolac for management of endodontic pain'. En conjunto forman una huella única.

Citar esto